enGene Therapeutics Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, enGene Therapeutics stock has a consensus rating of "Hold" and an average price target of $3.57. The average 1-year stock price forecast is 102.84% higher than the current stock price, while the lowest is $2.00 (+13.64%) and the highest is $6.00 (+240.91%).

Price Target: $3.57 (+102.84%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$2.00	$3.57	$4.00	$6.00
Change	+13.64%	+102.84%	+127.27%	+240.91%

Analyst Ratings

The average analyst rating for enGene Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	6	7	7	7	7	2
Buy	3	3	3	3	3	1
Hold	1	1	1	1	1	8
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	11	11	11	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Dai UBS	UBS	Hold Maintains $9 → $2	Hold	Maintains	$9 → $2	+13.64%	May 14, 2026
Mani Foroohar Leerink Partners	Leerink Partners	Hold Downgrades $2	Hold	Downgrades	$2	+13.64%	May 8, 2026
Andres Y. Maldonado H.C. Wainwright	H.C. Wainwright	Buy Reiterates $25 → $6	Buy	Reiterates	$25 → $6	+240.91%	May 8, 2026
Leland Gershell Oppenheimer	Oppenheimer	Hold Maintains n/a	Hold	Maintains	n/a	n/a	May 8, 2026
Sean McCutcheon Raymond James	Raymond James	Buy Maintains $27 → $4	Buy	Maintains	$27 → $4	+127.27%	May 8, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

15.16M

EPS This Year

-2.03

from -2.29

EPS Next Year

-1.99

from -2.03

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Oct 31, 2021	Oct 31, 2022	Oct 31, 2023	Oct 31, 2024	Oct 31, 2025	Oct 31, 2026	Oct 31, 2027
Revenue	-	-	-	-	-	-	15.16M
Revenue Growth	-	-	-	-	-	-	-
EPS	-6.25	-44.30	-151.22	-1.46	-2.29	-2.03	-1.99
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	14	14

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	33.5M
Avg	n/a	15.2M
Low	n/a	4.9M

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-1.83	-1.37
Avg	-2.03	-1.99
Low	-2.43	-2.46

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.